Tokyo Tape
Sign in
← Perseus Proteomics

Quarterly report · Q2

4882.TEDINET S100PJIS
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥48m2022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥72m2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥29m2021-04-01 → 2021-09-30StandaloneNet sales
Operating income−¥307m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income−¥246m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥289m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥482m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥264m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax−¥362m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥273m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥363m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income−¥599m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income−¥274m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥2.9bnat 2022-09-30StandaloneAssets
Total assets¥3.3bnat 2022-03-31StandaloneAssets
Total assets¥3.6bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥90mat 2022-09-30StandaloneLiabilities
Total liabilities¥148mat 2022-03-31StandaloneLiabilities
Net assets / equity¥2.8bnat 2022-09-30StandaloneNet assets
Net assets / equity¥3.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥3.5bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥2.8bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥3.2bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥2.8bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.5bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥256m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥477m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥205m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥156m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥34m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥20,0002022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.6bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.6bn2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-30.872022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.842022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-54.472021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-26.772021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-11.362021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio96.5%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio97.9%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued11,759,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued11,759,400at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued11,759,400at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 363
ItemContextValueUnit
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember-20000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember951000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember17252000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember2436929000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-394681000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1069300000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember3214852000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember3506229000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember2820171000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-11-11
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第23期第２四半期（自　2022年７月１日　至　2022年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社ペルセウスプロテオミクス
Company name in english cover pageFilingDateInstantPerseus Proteomics Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長執行役員　　横川　拓哉
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都目黒区駒場四丁目７番６号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-5738-1705（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役執行役員管理部長　　鈴川　信一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都目黒区駒場四丁目７番６号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-5738-1705（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役執行役員管理部長　　鈴川　信一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE35510
Fund codeFilingDateInstant－
Security codeFilingDateInstant48820
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社ペルセウスプロテオミクス
Filer name in englishFilingDateInstantPerseus Proteomics Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2022-04-01
Current period end dateFilingDateInstant2022-09-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2023-03-31
Previous fiscal year start dateFilingDateInstant2021-04-01
Comparative period end dateFilingDateInstant2021-09-30
Previous fiscal year end dateFilingDateInstant2022-03-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass